Loring Wolcott & Coolidge Fiduciary Advisors’s Itron ITRI Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio ITRI Stock Details ITRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-111	Closed	-$11K	–	850
2021 Q2	$11K	Buy	+111	New	+$10.3K	﹤0.01%	619
2021 Q1	–	Sell	-111	Closed	-$11K	–	506
2020 Q4	$11K	Buy	+111	New	+$8.53K	﹤0.01%	557
2018 Q4	–	Sell	-300	Closed	-$19K	–	709
2018 Q3	$19K	Buy	+300	New	+$18.9K	﹤0.01%	497
2014 Q3	–	Sell	-2,500	Closed	-$101K	–	606
2014 Q2	$101K	Sell	2,500 -9,035	-78%	-$344K	﹤0.01%	359
2014 Q1	$410K	Buy	11,535 +2,350	+26%	+$89K	0.01%	205
2013 Q4	$381K	Sell	9,185 -880	-9%	-$37.3K	0.01%	210
2013 Q3	$431K	Sell	10,065 -995	-9%	-$40.7K	0.01%	191
2013 Q2	$469K	Buy	+11,060	New	+$472K	0.01%	195

Other funds holding ITRI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's ITRI Position: Q3 2021 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Itron (ITRI) in Q3 2021, closing a stake of 111 shares — an estimated $11K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in ITRI in Q2 2013 and held it in 8 quarters. The position peaked at $469K in Q2 2013. 261 funds tracked by Wall St. Rank hold ITRI as of Q3 2021.

Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Itron position as of Q3 2021 after selling out during the quarter.
Loring Wolcott & Coolidge Fiduciary Advisors sold 111 Itron shares in Q3 2021, an estimated $11K.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Itron in Q2 2013 and held it in 8 quarters.
Loring Wolcott & Coolidge Fiduciary Advisors's Itron position peaked at $469K in Q2 2013.
261 funds tracked by Wall St. Rank held Itron as of Q3 2021.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.